Cargando…
Overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108862/ http://dx.doi.org/10.1186/1479-5876-12-S1-P8 |
| _version_ | 1782327799064821760 |
|---|---|
| author | Dummer, Reinhard Schadendorf, Dirk Ascierto, Paolo A Larkin, James Lebbé, Celeste Hauschild, Axel |
| author_facet | Dummer, Reinhard Schadendorf, Dirk Ascierto, Paolo A Larkin, James Lebbé, Celeste Hauschild, Axel |
| author_sort | Dummer, Reinhard |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4108862 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-41088622014-08-04 Overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials Dummer, Reinhard Schadendorf, Dirk Ascierto, Paolo A Larkin, James Lebbé, Celeste Hauschild, Axel J Transl Med Poster Presentation BioMed Central 2014-05-06 /pmc/articles/PMC4108862/ http://dx.doi.org/10.1186/1479-5876-12-S1-P8 Text en Copyright © 2014 Dummer et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Dummer, Reinhard Schadendorf, Dirk Ascierto, Paolo A Larkin, James Lebbé, Celeste Hauschild, Axel Overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials |
| title | Overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials |
| title_full | Overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials |
| title_fullStr | Overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials |
| title_full_unstemmed | Overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials |
| title_short | Overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials |
| title_sort | overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108862/ http://dx.doi.org/10.1186/1479-5876-12-S1-P8 |
| work_keys_str_mv | AT dummerreinhard overallsurvivalofpatientswithchemotherapynaiveadvancedmelanomatreatedwithipilimumab3mgkginclinicaltrials AT schadendorfdirk overallsurvivalofpatientswithchemotherapynaiveadvancedmelanomatreatedwithipilimumab3mgkginclinicaltrials AT asciertopaoloa overallsurvivalofpatientswithchemotherapynaiveadvancedmelanomatreatedwithipilimumab3mgkginclinicaltrials AT larkinjames overallsurvivalofpatientswithchemotherapynaiveadvancedmelanomatreatedwithipilimumab3mgkginclinicaltrials AT lebbeceleste overallsurvivalofpatientswithchemotherapynaiveadvancedmelanomatreatedwithipilimumab3mgkginclinicaltrials AT hauschildaxel overallsurvivalofpatientswithchemotherapynaiveadvancedmelanomatreatedwithipilimumab3mgkginclinicaltrials |